Travere Therapeutics, Inc.
TVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001438533
In the last 90 days, Travere Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $5.98B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Travere Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 218
- +22 vs. Q4 2024
- Shares held
- 98.1M
- +4.75M (+5.1%) vs. Q4 2024
- Total value
- $1.77B
- +$147.3M (+9.1%) vs. Q4 2024
- New holders
- 45
- 88 more added
- Sold out
- 23
- 56 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 320 | $5.98B |
| Q1 2026 | 261 | $3.01B |
| Q4 2025 | 278 | $3.90B |
| Q3 2025 | 238 | $2.41B |
| Q2 2025 | 213 | $1.49B |
| Q1 2025 | 218 | $1.77B |
| Q4 2024 | 197 | $1.66B |
| Q3 2024 | 178 | $1.16B |
| Q2 2024 | 174 | $723.4M |
| Q1 2024 | 175 | $677.4M |
| Q4 2023 | 165 | $769.6M |
| Q3 2023 | 169 | $737.2M |
| Q2 2023 | 169 | $1.27B |
| Q1 2023 | 175 | $1.89B |
| Q4 2022 | 155 | $1.53B |
| Q3 2022 | 171 | $1.72B |
| Q2 2022 | 171 | $1.68B |
| Q1 2022 | 169 | $1.79B |
| Q4 2021 | 169 | $2.04B |
| Q3 2021 | 148 | $1.48B |
| Q2 2021 | 136 | $900.8M |
| Q1 2021 | 150 | $1.56B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Travere Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Woodline Partners LP | 1,229,778 | $22.0M | 0.14% | −884,278−41.8% | Reduced |
| Morgan Stanley | 1,642,061 | $29.4M | 0.00% | −8,542−0.5% | Reduced |
| D. E. Shaw & Co., Inc. | 1,713,592 | $30.7M | 0.04% | −564,783−24.8% | Reduced |
| Kynam Capital Management, LP | 1,802,750 | $32.3M | 2.76% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,976,661 | $35.4M | 0.00% | +134,360+7.3% | Added |
| Emerald Advisers, LLC | 2,077,173 | $37.2M | 1.68% | −48,571−2.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 2,184,898 | $39.2M | 0.07% | +1,808,098+479.9% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 2,601,922 | $46.6M | 0.15% | −300,003−10.3% | Reduced |
| Renaissance Technologies LLC | 2,702,814 | $48.4M | 0.07% | +293,300+12.2% | Added |
| Driehaus Capital Management LLC | 2,767,693 | $49.6M | 0.48% | +549,718+24.8% | Added |
| Rock Springs Capital Management LP | 2,921,196 | $52.3M | 3.00% | −2,052,453−41.3% | Reduced |
| State Street Corp | 3,646,715 | $65.3M | 0.00% | −120,520−3.2% | Reduced |
| Macquarie Group Ltd | 4,797,314 | $86.0M | 0.11% | +537,757+12.6% | Added |
| Vanguard Group Inc | 5,014,020 | $89.9M | 0.00% | −1,728,145−25.6% | Reduced |
| BlackRock, Inc. | 8,190,544 | $146.8M | 0.00% | +172,252+2.1% | Added |
| Janus Henderson Group PLC | 7,528,622 | $148.1M | 0.08% | +3,469,990+85.5% | Added |
| Armistice Capital, LLC | 8,872,000 | $159.0M | 4.25% | +1,514,000+20.6% | Added |
| Whipplewood Advisors, LLC | 3 | – | – | −94−96.9% | Reduced |
| Logos Global Management LP | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −393,300−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −322,235−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −185,840−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −181,174−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −76,842−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −74,356−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −32,616−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −30,953−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −25,521−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −22,600−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −19,523−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −19,072−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −15,996−100.0% | Sold out |
| Syon Capital LLC | 0 | $0 | 0.00% | −15,435−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −13,242−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −4,048−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −3,050−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −401−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −285−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |